ストックスクリーナーアプリを入手
4.84
2.99%
-0.17
前日終値:
$5.01
開ける：
$5
24時間の取引高:
210.80K
Relative Volume:
0.54
時価総額：
$284.50M
収益：
-
当期純損益:
$-68.46M
株価収益率:
-4.84
EPS:
-1
ネットキャッシュフロー:
$-57.37M
1週間 パフォーマンス:
-13.21%
1か月 パフォーマンス:
-0.61%
6か月 パフォーマンス:
+62.00%
1年 パフォーマンス:
+504.18%
1日の値動き範囲:
$4.82
$5.14
1週間の範囲:
$4.66
$5.74
52週間の値動き範囲:
$0.72
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
名前
Rezolute Inc
セクター
電話
650-206-4507
住所
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
RZLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| RZLT | 4.84 | 284.50M | 0 | -68.46M | -57.37M | -1.00 |
| VRTX | 450.34 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.04 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.61 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.38 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-02 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-09-08 | 開始されました | ROTH Capital | Buy |
| 2021-05-27 | 開始されました | Oppenheimer | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
Rezolute Inc (RZLT) 最新ニュース
Wedbush Initiates Coverage of Rezolute (RZLT) with Outperform Recommendation - MSN
(RZLT) On The My Stocks Page - Stock Traders Daily
Institutional investors in Rezolute, Inc. (NASDAQ:RZLT) lost 11% last week but have reaped the benefits of longer-term growth - Simply Wall St
Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Rezolute's SWOT analysis: biotech stock eyes growth amid clinical progress - Investing.com India
We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully - Yahoo Finance
Rezolute stock soars to 52-week high, hits $6.1 amid surge By Investing.com - Investing.com South Africa
Rezolute stock soars to 52-week high, hits $6.1 amid surge - Investing.com India
(RZLT) Investment Report - Stock Traders Daily
Rezolute (NASDAQ:RZLT) Earns "Buy" Rating from HC Wainwright - MarketBeat
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - The Manila Times
Rezolute Advances Phase 3 Trials Despite $15.4M Loss; Maintains $117.8M Cash Position | RZLT Stock News - StockTitan
Equities Analysts Offer Predictions for Rezolute Q1 Earnings - MarketBeat
Wedbush Reaffirms “Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Rezolute (NASDAQ:RZLT) Given Outperform Rating at Wedbush - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Average Price Target from Brokerages - MarketBeat
(RZLT) Technical Pivots with Risk Controls - Stock Traders Daily
SEC Form DEFA14A filed by Rezolute Inc. - Quantisnow
AAO 2024: Rezolute’s RZ-402 shows promising Phase IIa results in DME patients - Yahoo Finance
With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing - Yahoo Finance
Cubist Systematic Strategies LLC Boosts Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan
Renaissance Technologies LLC Sells 149,660 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Cubist Systematic Strategies LLC - Defense World
Marshall Wace LLP Invests $4.50 Million in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) - Clinical Leader
Nantahala Capital Management LLC Cuts Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
XTX Topco Ltd Has $145,000 Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute's SWOT analysis: biotech firm's stock poised for growth amid clinical trials - Investing.com
Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update - MarketBeat
Rezolute (NASDAQ:RZLT) Receives Buy Rating from HC Wainwright - MarketBeat
Rezolute Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Rezolute Inc [RZLT] stock for 20,017 USD was acquired by Hogenhuis Wladimir - Knox Daily
Director Wladimir Hogenhuis Acquires 4,259 Shares of Rezolute In - GuruFocus.com
Affinity Asset Advisors LLC Acquires 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Affinity Asset Advisors LLC Purchases 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock By Investing.com - Investing.com Australia
Rezolute, Inc. (NASDAQ:RZLT) Director Wladimir Hogenhuis Buys 4,259 Shares - Defense World
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock - Investing.com
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - MSN
BTIG bullish on Rezolute stock as pivotal trials move forward and hold lifted - Investing.com Canada
Rezolute Inc [RZLT] Director makes an insider acquire of 4,815 shares worth 19,982. - Knox Daily
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS - Defense World
JMP Securities Reaffirms "Market Outperform" Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities Reiterates “Market Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World
Rezolute (NASDAQ:RZLT) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Rezolute Inc (RZLT) stock analysis: A simple moving average approach - US Post News
Rezolute Inc (RZLT) 財務データ
収益
当期純利益
現金流量
EPS
Rezolute Inc (RZLT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | Director |
Jun 25 '24 |
Buy |
4.15 |
4,815 |
19,982 |
37,508 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 14 '24 |
Buy |
3.91 |
4,300 |
16,828 |
54,352 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 14 '24 |
Buy |
3.91 |
3,300 |
12,916 |
13,000 |
| Evans Daron | CFO |
Jun 14 '24 |
Buy |
4.04 |
40,000 |
161,568 |
40,000 |
| Evans Daron | CFO |
May 29 '24 |
Buy |
3.50 |
451 |
1,578 |
121,351 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
May 23 '24 |
Buy |
2.69 |
7,500 |
20,138 |
50,052 |
| Evans Daron | CFO |
May 24 '24 |
Buy |
3.23 |
2,942 |
9,503 |
13,000 |
| Evans Daron | CFO |
May 23 '24 |
Buy |
2.85 |
58 |
165 |
10,058 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Mar 28 '24 |
Buy |
2.55 |
500 |
1,275 |
1,076 |
| Evans Daron | CFO |
Mar 15 '24 |
Buy |
1.69 |
20,000 |
33,830 |
20,000 |
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):